Global Non-Oncology Radiopharmaceuticals Market Outlook
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The non-Oncology Radiopharmaceuticals Market is anticipated to grow with a value CAGR of 9.6% over 2019-2028. According to a study published by Insure Insights on the Non-Oncology Radiopharmaceuticals, it suggests that Non-Oncology Radiopharmaceuticals are those radioactive drugs that are given for the treatment other than cancer, which includes for the treatment of thyroid, Cardiovascular diseases, etc. they are bound to biological molecules so as to target specific organs, tissues or cells within the human body. Changing Lifestyles, increased Awareness About Nuclear Medicine are the factors driving the market.
Top Driver: Radiopharmaceuticalsoffer a better diagnosis for different treatments
Diseases associated with lungs, Cardiac, Thyroid related problems are being diagnosed nowadays with the help of radiopharmaceuticals. A rise in awareness among people for radiopharmaceuticals need for better diagnosis is driving the market. For instance, The USFDA in June 2020 had awardedLillys pharmaceuticals with three approvals, especially for treating the patient with Alzheimers disease and lung cancer, etc., TAUVID a radioactive diagnostic agent was approved for diagnosing Alzheimers disease, they had also received approval for drug Taltzwhich is used in Treatment of Non-Radiographic Axial Spondyloarthritis
Diagnostic Nuclear medicine to make the highest contribution in the Non-Oncology Radiopharmaceuticals Market
Based on the Type segment, Radioactive pharmaceuticals have obtained significant growth in the diagnosis; It is reported that these drugs are efficient enough in targeting specific tissues, organs of the human body. For instance, In June 2020, FDA had approved Tauvidit as the first drug to image tau pathology, i.e., a distinctive characteristic of Alzheimers disease in the brain. This drug was injected intravenously before positron emission tomography (PET) imaging of the brain. In terms of the Application segment, Non-Oncology Radiopharmaceuticals have been obtained significant growth in the Therapeutic application segment due to the rise in thyroid disorders.
Technological Advancements to boost the North American Market
The ongoing Technological advancement, government funding for advanced healthcare are boosting the market of North America. Moreover, the rising awareness among people about radiopharmaceuticals is further enhancing the market growth. For instance, In the year 2018, NorthStar Medical Radioisotopes had obtained Federal approval to become the first U.S. supplier in 30 years, as the technology the developed can be used to produce a critical radioactive imaging product technetium-99mwhich is the most widely used radioisotope in medical imaging. FDA approved RadioGenix System that could produce technetium-99m, which is used in more than 10 million diagnostic procedures a year in the U.S. It is used to detect heart disease and cancer and to test lung, liver, kidney, and brain function.
Players to Focus on developing technologically advanced Radiopharmaceuticals
The major competitors of the Non-Oncology Radiopharmaceuticals Market are fragmented, and the competitors focus on developing new technologically advanced radiopharmaceuticals for providing better healthcare for cardia disorders, thyroid, etc. The key competitors of the Non-Oncology Radiopharmaceuticals Market are NTP Radioisotopes, JSC Isotope, NorthStar Medical Radioisotopes, Eckert & Ziegler, Institute of Isotopes Co., Ltd, Sinotau Pharmaceuticals, Isotopic Molecular Imaging Limited, BraccoImaging, GE Healthcare, and Lantheus Medical Imaging
NorthStar Medical Radioisotopes: NorthStar Medical Radioisotopes is a key competitor of the Non-Oncology Radiopharmaceuticals, and is also a global innovator in the production and distribution of radioisotopes especially used in medical imaging, for instance In February 2020 FDA had approved the addition of two molybdenum-99 (Mo-99) filling lines in Columbia, In addition with the filling lines, is a part of NorthStars ongoing expansion plans to increase production and capacity of domestic, non-uranium based Mo-99 for the U.S. healthcare system.
Isotopia Molecular Imaging Limited: Isotopia Molecular Imaging Limited, is a popular competitor player in the Global Market for Non-Oncology Radiopharmaceuticals. For instance, in the year 2018,Isotopia Company had collaborated with Bar-Ilan U for developing a new method in the treatment of prostate cancer. In this collaboration, a study was being conducted to develop a radioactive marker, with an aim to find out the distinction between tumors and inflammation for enhanced diagnosis.
Scope of the Report
By Type
Diagnostic Nuclear Medicine
Brachytherapy Isotopes
Therapeutic Nuclear Medicine
By Application
SPECT Applications
Therapeutic Applications
PET Applications
By Region
North America
Europe
Asia Pacific
Rest Of World
Top Driver: Radiopharmaceuticalsoffer a better diagnosis for different treatments
Diseases associated with lungs, Cardiac, Thyroid related problems are being diagnosed nowadays with the help of radiopharmaceuticals. A rise in awareness among people for radiopharmaceuticals need for better diagnosis is driving the market. For instance, The USFDA in June 2020 had awardedLillys pharmaceuticals with three approvals, especially for treating the patient with Alzheimers disease and lung cancer, etc., TAUVID a radioactive diagnostic agent was approved for diagnosing Alzheimers disease, they had also received approval for drug Taltzwhich is used in Treatment of Non-Radiographic Axial Spondyloarthritis
Diagnostic Nuclear medicine to make the highest contribution in the Non-Oncology Radiopharmaceuticals Market
Based on the Type segment, Radioactive pharmaceuticals have obtained significant growth in the diagnosis; It is reported that these drugs are efficient enough in targeting specific tissues, organs of the human body. For instance, In June 2020, FDA had approved Tauvidit as the first drug to image tau pathology, i.e., a distinctive characteristic of Alzheimers disease in the brain. This drug was injected intravenously before positron emission tomography (PET) imaging of the brain. In terms of the Application segment, Non-Oncology Radiopharmaceuticals have been obtained significant growth in the Therapeutic application segment due to the rise in thyroid disorders.
Technological Advancements to boost the North American Market
The ongoing Technological advancement, government funding for advanced healthcare are boosting the market of North America. Moreover, the rising awareness among people about radiopharmaceuticals is further enhancing the market growth. For instance, In the year 2018, NorthStar Medical Radioisotopes had obtained Federal approval to become the first U.S. supplier in 30 years, as the technology the developed can be used to produce a critical radioactive imaging product technetium-99mwhich is the most widely used radioisotope in medical imaging. FDA approved RadioGenix System that could produce technetium-99m, which is used in more than 10 million diagnostic procedures a year in the U.S. It is used to detect heart disease and cancer and to test lung, liver, kidney, and brain function.
Players to Focus on developing technologically advanced Radiopharmaceuticals
The major competitors of the Non-Oncology Radiopharmaceuticals Market are fragmented, and the competitors focus on developing new technologically advanced radiopharmaceuticals for providing better healthcare for cardia disorders, thyroid, etc. The key competitors of the Non-Oncology Radiopharmaceuticals Market are NTP Radioisotopes, JSC Isotope, NorthStar Medical Radioisotopes, Eckert & Ziegler, Institute of Isotopes Co., Ltd, Sinotau Pharmaceuticals, Isotopic Molecular Imaging Limited, BraccoImaging, GE Healthcare, and Lantheus Medical Imaging
NorthStar Medical Radioisotopes: NorthStar Medical Radioisotopes is a key competitor of the Non-Oncology Radiopharmaceuticals, and is also a global innovator in the production and distribution of radioisotopes especially used in medical imaging, for instance In February 2020 FDA had approved the addition of two molybdenum-99 (Mo-99) filling lines in Columbia, In addition with the filling lines, is a part of NorthStars ongoing expansion plans to increase production and capacity of domestic, non-uranium based Mo-99 for the U.S. healthcare system.
Isotopia Molecular Imaging Limited: Isotopia Molecular Imaging Limited, is a popular competitor player in the Global Market for Non-Oncology Radiopharmaceuticals. For instance, in the year 2018,Isotopia Company had collaborated with Bar-Ilan U for developing a new method in the treatment of prostate cancer. In this collaboration, a study was being conducted to develop a radioactive marker, with an aim to find out the distinction between tumors and inflammation for enhanced diagnosis.
Scope of the Report
By Type
Diagnostic Nuclear Medicine
Brachytherapy Isotopes
Therapeutic Nuclear Medicine
By Application
SPECT Applications
Therapeutic Applications
PET Applications
By Region
North America
Europe
Asia Pacific
Rest Of World
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Non-Oncology Radiopharmaceuticals Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Non-Oncology Radiopharmaceuticals Market -Industry Snapshots
6.1 Overview
6.1.1 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Non-Oncology Radiopharmaceuticals Market Analysis, by Type
7.1 Overview
7.2 Key Findings for Non-Oncology Radiopharmaceuticals Market - By Type
7.2.1 Non-Oncology Radiopharmaceuticals Market -Diagnostic Nuclear Medicine
7.2.2 Non-Oncology Radiopharmaceuticals Market -Brachytherapy Isotopes
7.2.3 Non-Oncology Radiopharmaceuticals Market - Therapeutic Nuclear Medicine
Chapter 8 Global Non-Oncology Radiopharmaceuticals Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Non-Oncology Radiopharmaceuticals Market - By Application
8.2.1 Non-Oncology Radiopharmaceuticals Market -SPECT Applications
8.2.2 Non-Oncology Radiopharmaceuticals Market - Therapeutic Applications
8.2.3 Non-Oncology Radiopharmaceuticals Market - PET Applications
Chapter 9 Non-Oncology Radiopharmaceuticals Market Analysis by Region
9.1 Key Findings for Non-Oncology Radiopharmaceuticals Market - By region
9.2 Overview
9.2.1 Global Non-Oncology Radiopharmaceuticals Market Analysis, By Type, 2019 - 2026
9.2.2 Global Non-Oncology Radiopharmaceuticals Market Analysis, By Application, 2019 - 2026
9.3 Non-Oncology Radiopharmaceuticals Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Application
9.4 Non-Oncology Radiopharmaceuticals Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Application
9.5 Non-Oncology Radiopharmaceuticals Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Application
9.6 Non-Oncology Radiopharmaceuticals Market Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 Latin America
9.6.4 Rest Of World
9.6.5 Latin America, Middle East and Africa Market, By Type
9.6.6 Latin America, Middle East and Africa Market, By Application
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1 NTP Radioisotopes
11.1.1 Business Fundamentals
11.1.2 Financial Snapshots
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.2 JSC Isotope
11.3 NorthStar Medical Radioisotopes
11.4 Eckert & Ziegler
11.5 Institute of Isotopes Co., Ltd
11.6 Sinotau Pharmaceuticals
11.7 Isotopia Molecular Imaging Limited
11.8 Bracco Imaging
11.9 GE Healthcare
11.10 Lantheus Medical Imaging
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
TABLE 2 Non-Oncology Radiopharmaceuticals Market by Type 2, 2018 - 2026 (USD Million)
TABLE 3 Non-Oncology Radiopharmaceuticals Market by Type 3, 2018 - 2026 (USD Million)
TABLE 4 Non-Oncology Radiopharmaceuticals Market by Type 4, 2018 - 2026 (USD Million)
TABLE 5 Non-Oncology Radiopharmaceuticals Market by Application 1, 2018 - 2026 (USD Million)
TABLE 6 Non-Oncology Radiopharmaceuticals Market by Application 2, 2018 - 2026 (USD Million)
TABLE 7 Non-Oncology Radiopharmaceuticals Market by Application 3, 2018 - 2026 (USD Million)
TABLE 8 Non-Oncology Radiopharmaceuticals Market by Application 4, 2018 - 2026 (USD Million)
TABLE 9 Global Non-Oncology Radiopharmaceuticals Market Value, By Type, 2019 - 2026 (US$ Bn)
TABLE 10 Global Non-Oncology Radiopharmaceuticals Market Value, By Application, 2019 - 2026 (US$ Bn)
TABLE 11 Non-Oncology Radiopharmaceuticals Market Analysis by North America (USD Million), 2018-2026
TABLE 12 U.S. Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 13 U.S. Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 14 U.S. Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 15 Canada Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 16 Canada Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 17 Canada Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 18 MexicoNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 19 MexicoNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 20 MexicoNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 21 Non-Oncology Radiopharmaceuticals Market Analysis by Europe (USD Million), 2018-2026
TABLE 22 GermanyNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 23 GermanyNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 24 GermanyNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 25 United KingdomNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 26 United KingdomNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 27 United KingdomNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 28 FranceNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 29 FranceNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 30 FranceNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 31 ItalyNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 32 ItalyNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 33 ItalyNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 34 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 35 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 36 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 37 Non-Oncology Radiopharmaceuticals Market Analysis by Asia Pacific (USD Million), 2018-2026
TABLE 38 ChinaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 39 ChinaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 40 ChinaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 41 JapanNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 42 JapanNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 43 JapanNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 44 IndiaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 45 IndiaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 46 IndiaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 47 Rest of APACNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 48 Rest of APACNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 49 Rest of APACNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 50 Non-Oncology Radiopharmaceuticals Market Analysis by Rest Of World (USD Million), 2018-2026
TABLE 51 Middle East & Africa (MEA)Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 52 Middle East & Africa (MEA) Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 53 Middle East & Africa (MEA) Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 54 Latin AmericaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 55 Latin AmericaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 56 Latin AmericaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 57 Rest Of WorldNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 58 Rest Of WorldNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 59 Rest Of WorldNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
Chapter 1
FIG. 2 Global Non-Oncology Radiopharmaceuticals Market : Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Non-Oncology Radiopharmaceuticals Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Non-Oncology Radiopharmaceuticals Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 10 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 11 North America Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 12 Non-Oncology Radiopharmaceuticals Market Segment 1 North America
FIG. 13 Non-Oncology Radiopharmaceuticals Market Segment 2 North America
FIG. 14 Non-Oncology Radiopharmaceuticalss U.S. outlook, 2019 & 2026
FIG. 15 Non-Oncology Radiopharmaceuticalss Canada outlook, 2019 & 2026
FIG. 16 Non-Oncology Radiopharmaceuticalss Mexico outlook, 2019 & 2026
FIG. 17 Europe Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 18 Non-Oncology Radiopharmaceuticals Market Segment 1 Europe
FIG. 19 Non-Oncology Radiopharmaceuticals Market Segment 2 Europe
FIG. 20 Non-Oncology Radiopharmaceuticalss Germany outlook, 2019 & 2026
FIG. 21 Non-Oncology Radiopharmaceuticalss United Kingdom outlook, 2019 & 2026
FIG. 22 Non-Oncology Radiopharmaceuticalss France outlook, 2019 & 2026
FIG. 23 Non-Oncology Radiopharmaceuticalss Italy outlook, 2019 & 2026
FIG. 24 Non-Oncology Radiopharmaceuticalss Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 26 Non-Oncology Radiopharmaceuticals Market Segment 1 Asia Pacific
FIG. 27 Non-Oncology Radiopharmaceuticals Market Segment 2 Asia Pacific
FIG. 28 Non-Oncology Radiopharmaceuticalss China outlook, 2019 & 2026
FIG. 29 Non-Oncology Radiopharmaceuticalss Japan outlook, 2019 & 2026
FIG. 30 Non-Oncology Radiopharmaceuticalss India outlook, 2019 & 2026
FIG. 31 Non-Oncology Radiopharmaceuticalss Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 33 Non-Oncology Radiopharmaceuticals Market Segment 1 Rest Of World
FIG. 34 Non-Oncology Radiopharmaceuticals Market Segment 2 Rest Of World
FIG. 35 Non-Oncology Radiopharmaceuticalss Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Non-Oncology Radiopharmaceuticalss Latin America outlook, 2019 & 2026
FIG. 37 Non-Oncology Radiopharmaceuticalss Rest Of World outlook, 2019 & 2026
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Non-Oncology Radiopharmaceuticals Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Non-Oncology Radiopharmaceuticals Market -Industry Snapshots
6.1 Overview
6.1.1 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Non-Oncology Radiopharmaceuticals Market Analysis, by Type
7.1 Overview
7.2 Key Findings for Non-Oncology Radiopharmaceuticals Market - By Type
7.2.1 Non-Oncology Radiopharmaceuticals Market -Diagnostic Nuclear Medicine
7.2.2 Non-Oncology Radiopharmaceuticals Market -Brachytherapy Isotopes
7.2.3 Non-Oncology Radiopharmaceuticals Market - Therapeutic Nuclear Medicine
Chapter 8 Global Non-Oncology Radiopharmaceuticals Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Non-Oncology Radiopharmaceuticals Market - By Application
8.2.1 Non-Oncology Radiopharmaceuticals Market -SPECT Applications
8.2.2 Non-Oncology Radiopharmaceuticals Market - Therapeutic Applications
8.2.3 Non-Oncology Radiopharmaceuticals Market - PET Applications
Chapter 9 Non-Oncology Radiopharmaceuticals Market Analysis by Region
9.1 Key Findings for Non-Oncology Radiopharmaceuticals Market - By region
9.2 Overview
9.2.1 Global Non-Oncology Radiopharmaceuticals Market Analysis, By Type, 2019 - 2026
9.2.2 Global Non-Oncology Radiopharmaceuticals Market Analysis, By Application, 2019 - 2026
9.3 Non-Oncology Radiopharmaceuticals Market North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Application
9.4 Non-Oncology Radiopharmaceuticals Market Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Application
9.5 Non-Oncology Radiopharmaceuticals Market Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Application
9.6 Non-Oncology Radiopharmaceuticals Market Rest Of World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 Latin America
9.6.4 Rest Of World
9.6.5 Latin America, Middle East and Africa Market, By Type
9.6.6 Latin America, Middle East and Africa Market, By Application
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1 NTP Radioisotopes
11.1.1 Business Fundamentals
11.1.2 Financial Snapshots
11.1.3 Product Portfolio
11.1.4 Recent Developments
11.2 JSC Isotope
11.3 NorthStar Medical Radioisotopes
11.4 Eckert & Ziegler
11.5 Institute of Isotopes Co., Ltd
11.6 Sinotau Pharmaceuticals
11.7 Isotopia Molecular Imaging Limited
11.8 Bracco Imaging
11.9 GE Healthcare
11.10 Lantheus Medical Imaging
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 12 Appendix
List Of Tables
TABLE 1 Non-Oncology Radiopharmaceuticals Market by Type 1, 2018 - 2026 (USD Million)TABLE 2 Non-Oncology Radiopharmaceuticals Market by Type 2, 2018 - 2026 (USD Million)
TABLE 3 Non-Oncology Radiopharmaceuticals Market by Type 3, 2018 - 2026 (USD Million)
TABLE 4 Non-Oncology Radiopharmaceuticals Market by Type 4, 2018 - 2026 (USD Million)
TABLE 5 Non-Oncology Radiopharmaceuticals Market by Application 1, 2018 - 2026 (USD Million)
TABLE 6 Non-Oncology Radiopharmaceuticals Market by Application 2, 2018 - 2026 (USD Million)
TABLE 7 Non-Oncology Radiopharmaceuticals Market by Application 3, 2018 - 2026 (USD Million)
TABLE 8 Non-Oncology Radiopharmaceuticals Market by Application 4, 2018 - 2026 (USD Million)
TABLE 9 Global Non-Oncology Radiopharmaceuticals Market Value, By Type, 2019 - 2026 (US$ Bn)
TABLE 10 Global Non-Oncology Radiopharmaceuticals Market Value, By Application, 2019 - 2026 (US$ Bn)
TABLE 11 Non-Oncology Radiopharmaceuticals Market Analysis by North America (USD Million), 2018-2026
TABLE 12 U.S. Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 13 U.S. Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 14 U.S. Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 15 Canada Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 16 Canada Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 17 Canada Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 18 MexicoNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 19 MexicoNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 20 MexicoNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 21 Non-Oncology Radiopharmaceuticals Market Analysis by Europe (USD Million), 2018-2026
TABLE 22 GermanyNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 23 GermanyNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 24 GermanyNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 25 United KingdomNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 26 United KingdomNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 27 United KingdomNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 28 FranceNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 29 FranceNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 30 FranceNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 31 ItalyNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 32 ItalyNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 33 ItalyNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 34 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 35 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 36 Rest Of EuropeNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 37 Non-Oncology Radiopharmaceuticals Market Analysis by Asia Pacific (USD Million), 2018-2026
TABLE 38 ChinaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 39 ChinaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 40 ChinaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 41 JapanNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 42 JapanNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 43 JapanNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 44 IndiaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 45 IndiaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 46 IndiaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 47 Rest of APACNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 48 Rest of APACNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 49 Rest of APACNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 50 Non-Oncology Radiopharmaceuticals Market Analysis by Rest Of World (USD Million), 2018-2026
TABLE 51 Middle East & Africa (MEA)Non-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 52 Middle East & Africa (MEA) Non-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 53 Middle East & Africa (MEA) Non-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 54 Latin AmericaNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 55 Latin AmericaNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 56 Latin AmericaNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
TABLE 57 Rest Of WorldNon-Oncology Radiopharmaceuticals Market 2018 - 2026 (USD Million)
TABLE 58 Rest Of WorldNon-Oncology Radiopharmaceuticals Market By Type, 2018 - 2026 (USD Million)
TABLE 59 Rest Of WorldNon-Oncology Radiopharmaceuticals Market By Application, 2018 - 2026 (USD Million)
Chapter 1
List Of Figures
FIG. 1 Global Non-Oncology Radiopharmaceuticalss: Market SegmentationFIG. 2 Global Non-Oncology Radiopharmaceuticals Market : Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Non-Oncology Radiopharmaceuticals Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Non-Oncology Radiopharmaceuticals Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 10 Global Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 11 North America Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 12 Non-Oncology Radiopharmaceuticals Market Segment 1 North America
FIG. 13 Non-Oncology Radiopharmaceuticals Market Segment 2 North America
FIG. 14 Non-Oncology Radiopharmaceuticalss U.S. outlook, 2019 & 2026
FIG. 15 Non-Oncology Radiopharmaceuticalss Canada outlook, 2019 & 2026
FIG. 16 Non-Oncology Radiopharmaceuticalss Mexico outlook, 2019 & 2026
FIG. 17 Europe Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 18 Non-Oncology Radiopharmaceuticals Market Segment 1 Europe
FIG. 19 Non-Oncology Radiopharmaceuticals Market Segment 2 Europe
FIG. 20 Non-Oncology Radiopharmaceuticalss Germany outlook, 2019 & 2026
FIG. 21 Non-Oncology Radiopharmaceuticalss United Kingdom outlook, 2019 & 2026
FIG. 22 Non-Oncology Radiopharmaceuticalss France outlook, 2019 & 2026
FIG. 23 Non-Oncology Radiopharmaceuticalss Italy outlook, 2019 & 2026
FIG. 24 Non-Oncology Radiopharmaceuticalss Rest Of Europe outlook, 2019 & 2026
FIG. 25 Asia Pacific Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 26 Non-Oncology Radiopharmaceuticals Market Segment 1 Asia Pacific
FIG. 27 Non-Oncology Radiopharmaceuticals Market Segment 2 Asia Pacific
FIG. 28 Non-Oncology Radiopharmaceuticalss China outlook, 2019 & 2026
FIG. 29 Non-Oncology Radiopharmaceuticalss Japan outlook, 2019 & 2026
FIG. 30 Non-Oncology Radiopharmaceuticalss India outlook, 2019 & 2026
FIG. 31 Non-Oncology Radiopharmaceuticalss Rest of APAC outlook, 2019 & 2026
FIG. 32 Rest Of World Non-Oncology Radiopharmaceuticals Market Value, 2019 - 2026, (US$ Bn)
FIG. 33 Non-Oncology Radiopharmaceuticals Market Segment 1 Rest Of World
FIG. 34 Non-Oncology Radiopharmaceuticals Market Segment 2 Rest Of World
FIG. 35 Non-Oncology Radiopharmaceuticalss Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 36 Non-Oncology Radiopharmaceuticalss Latin America outlook, 2019 & 2026
FIG. 37 Non-Oncology Radiopharmaceuticalss Rest Of World outlook, 2019 & 2026
RELATED REPORTS
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
